Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
tremelimumab
Pharma
ASCO: AZ's latest Tagrisso data receive standing ovation
Tagrisso delivered a 84% progression-free survival benefit in EGFR-mutated NSCLC, as Imfinzi cut the risk of death by 27% in LS-SCLC.
Angus Liu
Jun 3, 2024 7:37am
AstraZeneca’s Imfinzi tackles another type of lung cancer
Apr 5, 2024 10:22am
BMS, AZ settle cancer immunotherapy patent suits for $510M
Aug 1, 2023 10:09am
BMS claims AstraZeneca's Imjudo violates two Yervoy patents
Jan 24, 2023 4:13pm
AZ's Imjudo faces more fierce competition after new cancer nod
Nov 11, 2022 10:00am
'The Top Line': Biogen's earnings call, AstraZeneca's CTLA-4 nod
Oct 28, 2022 6:00am
